Physician profile
David Basch
NPI 1053322354
$3,447.32
in general payments reported to CMS, 2019-2025
25 companies · $367 in 2025
The $367 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $692 · 2020: $406 · 2021: $554 · 2022: $746 · 2023: $379 · 2024: $304 · 2025: $367.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,050.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,049.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,311.03 | 2021-2025 | Atlantis Anterior Cervical Plate System, Mazor X System, Catalyft Pl Expandable Interbody System |
| Royal Biologics, INC. | $455.15 | 2020-2025 | |
| Baxter Healthcare | $249.90 | 2019-2023 | Actifuse |
| Pacira Therapeutics, INC. | $238.62 | 2019-2020 | |
| Pfizer INC. | $134.67 | 2019-2021 | |
| Si-Bone, INC. | $121.32 | 2019-2022 | |
| Choice Spine, LLC | $108.49 | 2021 | |
| Nuvasive, INC. | $107.01 | 2019-2020 | |
| Spine Wave, INC. | $88.70 | 2019 | |
| Smith+Nephew, INC. | $82.63 | 2022-2024 | Rf20000 |
| Depuy Synthes Sales INC. | $82.37 | 2019-2024 | Monovisc |
| Stryker Corporation | $69.45 | 2022 | |
| Bioventus LLC | $58.93 | 2019-2020 | |
| Horizon Therapeutics Plc | $53.73 | 2019 | |
| Abbott Laboratories | $49.98 | 2021 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integrity Implants INC. | $49.23 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $30.00 | 2022-2023 | Seglentis |
| Fidia Pharma USA INC. | $29.52 | 2023 | Triluron, Hymovis |
| Ethicon US, LLC | $23.55 | 2019 | |
| Medtronic USA, INC. | $22.50 | 2020 | |
| Linkbio Corp | $20.04 | 2025 | |
| Convatec INC. | $18.93 | 2023 | |
| Arteriocyte Medical Systems, INC. | $15.19 | 2021 | |
| Vertical Pharmaceuticals, LLC | $14.58 | 2019 | |
| Avanos Medical | $11.80 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Basch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.